Sternberg EM, Van Woert MH, Young SN, et al. Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
N Engl J Med. 1980;303:782–787.
Joly P, Lampert A, Thomine E, et al. Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.
J Am Acad Dermatol.
1991;25:332–333.
Auffranc JC, Berbis P, Fabre JF, et al. Sclerodermiform and poikilodermal syndrome observed during treatment with carbidopa and 5-hydroxytryptophan [translated from French].
Ann Dermatol Venereol.
1985;112:691–692.
Robertson DR, Higginson I, Macklin BS, et al. The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.
Br J Clin Pharmacol. 1991;31:413–417.
Campbell NR, Hasinoff BB. Iron supplements: a common cause of drug interactions.
Br J Clin Pharmacol. 1991;31:251–255.
Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism [letter].
J Neurol Neurosurg Psychiatry.
1995;58:639–640.
Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism [letter].
J Neurol Neurosurg Psychiatry.
1995;58:639–640.
Liu X, Lamango N, Charlton C. L-dopa depletes S-adenosylmethionine and increases S-adenosyl homocysteine: Relationship to the wearing off effects.
Soc Neurosci.
1998;24:1469.
Bottiglieri T, Hyland K, Reynolds EH. The clinical potential in ademetionine (S-adenosylmethionine) in neurological disorders.
Drugs.
1994;48:137–152.
Carrieri PB, Indaco A, Gentile S, et al. S-adenosylmethionine treatment of depression in patients with Parkinson's disease: a double-blind, crossover study versus placebo.
Curr Ther Res.
1990;48:154–160.
Liu X, Lamango N, Charlton C. L-dopa depletes S-adenosylmethionine and increases S-adenosyl homocysteine: Relationship to the wearing off effects.
Soc Neurosci.
1998;24:1469.
Snider SR. Octacosanol in parkinsonism [letter].
Ann Neurol.
1984;16:723.
Drug evaluations subscription (section 4, chapter 2). Volume I. Chicago: American Medical Association, Summer 1992: 12.
Sunagane N, Aikawa M, Ohta T, et al. Possibility of Interactions between Prescription Drugs and OTC Drugs (2nd Report)-Interaction between Levodopa Preparation and OTC Kampo Medicines for Upset Stomach-.
Yakugaku Zasshi. 2006;126:1191-6.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.